SCI Abstract

search
Discovery of HDM2004, a potent, selective and orally bioavailable HPK1 inhibitor for tumor immunotherapy
Hematopoietic progenitor kinase 1 (HPK1, also known as MAP4K1) is a serine/threonine kinase belonging to the Ste20-related...
Design and synthesis of c-Met/PARP dual-target inhibitors for the treatment of BRCA wild-type TNBC
The triple-negative breast cancer (TNBC) accounts for approximately 15% to 20% of all breast carcinomas with a worse progn...
Design, synthesis and preclinical evaluation of a tumor extracellular nucleotidase CD73 targeted theranostic radiotracer
Malignant tumors have become a significant public health challenge threatening human health. Although significant progress...
Optimization of triazole-based small molecule disruptors of the Aha1/Hsp90 complex that manifest potent activities
Recent structure-activity relationship (SAR) studies identified multiple Hsp90/Aha1 small molecule disruptors that manifes...
Current landscape and therapeutic prospects of indole-azole hybrids for colorectal cancer treatment: A mini-review
Colorectal cancer (CRC) constitutes a formidable global health burden and ranks among the leading causes of cancer-related...
An AI-based approach accelerates the discovery of protein–protein interaction modulators targeting NCS-1
Drug repurposing is an efficient strategy to accelerate the identification of therapeutic compounds by finding new uses fo...
Identification and optimization of first-in-class RNA helicase inhibitors of DDX1, LGP2, and MDA5
RNA helicases are essential, dynamic proteins that consume ATP to unwind and rearrange RNA. These activities place RNA hel...
Optimization of the fragment binding to hinge region for a potent PIM kinase inhibitor based on N-pyridinyl amide scaffold
Kinases are enzymes that transfer terminal phosphate group of the adenosine triphosphate (ATP) to specific substrate to re...
Phenoxy-linked colchicine derivatives: A structure-based approach toward enhanced selectivity and α-tubulin interaction
Cancer is a heterogeneous group of diseases marked by uncontrolled cell proliferation and metastasis, a major cause of can...
Medicinal chemistry approaches to the discovery and development of p300/CBP inhibitors for cancer therapy
The transcriptional coactivators p300 and CBP (CREB-binding protein) play a central role in gene regulation by functioning...
Methylenedioxy open-loop and closed-loop aporphines designed for the evaluation of potential antidepressants
For psychomodulators, some fragments in the chemical structures will play a decisive role in the regulation of certain key...
Rational design of NAMPT-based dual inhibitors with improved drug-like and pharmacokinetic properties for cancer treatment
Immunotherapy targeting the PD-1/PD-L1 axis has emerged as a transformative strategy in cancer treatment [1]. By reinvigor...
Targeting voltage-gated proton channel HV1: Optimised 5-phenyl-2-aminoimidazoles with anticancer potential
The voltage-gated proton channel (HV1) has been linked to the development of tumours, neuroinflammatory diseases, immune d...
Discovery of a novel and potent antiplatelet thiol prodrug CG-0255
Cardiovascular and cerebrovascular diseases remain the leading cause of deaths worldwide with nearly half of the deaths be...
Targeting α4β1 integrin: from cyclic to linear ligands, effects of chemical modifications
The immune system depends on integrins for adhesion and migration during leukocyte trafficking and for intracellular signa...